Introduction
Peritoneal dialysis (PD) solution should not contain bioincompatible elements such as high glucose, low pH, and glucose degradation products (GDPs) (1, 2) . Those bioincompatible elements promote peritoneal fibrosis, hyalinizing vasculopathy, deposition of advanced glycation end-products (AGEs), and angiogenesis (3, 4) , which in turn lead to membrane hyperpermeability and reduced ultrafiltration capacity because of the involvement of several factors, including transforming growth factor-β, vascular endothelial growth factor, aquaporin-1, and endothelial nitric oxide synthase (5) (6) (7) (8) .
Recently, biocompatible PD solutions have been developed to prevent PD-related peritoneal damage and potentially to prolong the duration of PD treatment.
These biocompatible PD solutions include neutral-pH solutions buffered with lactate or bicarbonate, low-GDP solutions that do not require heat sterilization, and solutions with icodextrin and amino acids instead of glucose as osmolar substances; all have been used in combination with conventional PD solutions (9) . Lactate-buffered neutral PD solutions with low GDPs achieved using a two-chambered bag system were introduced for clinical use in Japan more than a decade ago. These biocompatible solutions are expected to reduce morphologic and functional peritoneal deterioration and the incidence rate of encapsulating peritoneal sclerosis, a devastating complication of PD.
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The effectiveness of the new solutions for the prevention of peritoneal fibrosis and angiogenesis has been demonstrated experimentally (10) (11) (12) (13) . Several clinical studies have evaluated their effects (14, 15) , and the results of those studies indicated their usefulness in maintaining peritoneal integrity. However, the histologic effects of the new solutions on human peritoneal membrane pathology have not been evaluated. We hypothesized that use of neutral low-GDP solutions may improve peritoneal membrane deterioration by suppression of peritoneal AGE accumulation. To confirm that hypothesis, we set out in the present study to elucidate the histologic effects of low-GDP solutions by evaluating peritoneal biopsy samples obtained from patients treated solely with either conventional acidic solutions with high GDPs or neutral low-GDP solutions, both of which are buffered with lactate. Possible relationships between the use of the new PD solutions and peritoneal membrane pathology are discussed in terms of their clinical relevance.
Materials and Methods

Clinical findings of the PD patients
Between 1980 and 2010, we treated 379 patients with PD and performed 205 peritoneal biopsies at our center. The present study enrolled 29 patients at catheter insertion (pre-PD) and 176 at catheter removal (post-PD). To eliminate any influence of peritonitis on peritoneal Kawanishi et al.
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histology, patients with a history of peritonitis during PD therapy were excluded from the study. Because neutral solutions have been used clinically only since 2002 at our center, a limited number of patients (n = 12) had been treated solely using such solutions (Dianeal-N:
Baxter, Tokyo, Japan; Perisate N: JMS, Tokyo, Japan). Patients for the acidic group were selected from among 43 patients treated solely with acidic solution (Dianeal: Baxter; Perisate: JMS), who were matched with the patients of the neutral group based on age, sex, PD duration, and number in the group (n = 12). All patients underwent peritoneal biopsy at the time of PD catheter removal or when they withdrew from PD therapy. All clinical information was collected from medical records. Approval for the study was obtained from the Tokyo below 400 mL. The reasons for PD withdrawal in the study cohort were PD-related problems such as ultrafiltration failure (acidic group: n = 8; neutral group: n = 3), desire to transfer to hemodialysis (acidic group: n = 2; neutral group: n = 2), renal transplantation (acidic group: n = 2; neutral group: n = 5), and other (neutral group: n = 2). As a control, pre-PD samples were selected randomly from 13 of 29 patients who underwent peritoneal biopsy at the time of PD catheter insertion. Among the 13 patients who provided pre-PD samples (9 men, 4 women), mean age was 48.2 ± 4.2 years, mean serum creatinine was 8.01 ± 0.63 mg/dL, estimated glomerular filtration rate was 6.96 ± 0.60 mL/min/1.73 m2, and primary causes of renal failure were chronic glomerulonephritis (n = 8), diabetes mellitus (n = 1), and other (n = 4).
Histological evaluation for peritoneal fibrosis and vascular sclerosis
Peritoneal biopsy specimens were cut by scalpel to approximately 1 cm×≤5 mm and processed using routine pathology procedures. Two pathology experts, blinded to the clinical backgrounds of the patients, jointly reviewed the samples to arrive at a consensus evaluation.
The extent of peritoneal fibrosis and of vascular sclerosis was evaluated as previously reported (16) . Briefly, for the evaluation of peritoneal fibrosis, we calculated the average thickness (μm) at 5 random points within the submesothelial compact zone (SMC) between the basal border of the surface mesothelial cells and the upper border of peritoneal adipose Kawanishi et al. 
Evaluation of AGE accumulation
Accumulation of AGE in the interstitium and vasculature was evaluated by a semi-quantitative grading method: grade 0, no AGE accumulation; grade 1, mild accumulation; grade 2, moderate accumulation; and grade 3, severe accumulation (17) . The total grade score for AGE accumulation in the interstitium and vasculature were analyzed in association with PD duration.
Evaluation of vessel density using CD31 and Podoplanin immunostaining
The total of CD31-positive vessels and podoplanin positive lymphatic vessels located in the peritoneal interstitium were assessed under 200× magnification using a Leica DMD108 digital microscope (Leica Microsystems, Wetzlar, Germany). The type of CD31-positive vessel (capillary or PCV) was determined based on the external diameter (in micrometers) along the short axis: vessels less than 15 μm in diameter were defined as capillaries; those 15 -100 μm in diameter were defined as PCVs. The density of each vessel type was calculated as the average number of vessels per area (square millimeter), assessed in 5 randomly selected fields of the specimen.
Results
Clinical findings
Age and PD duration did not differ significantly between the acidic-and neutral-solution groups (Table 1) . High-glucose PD solution was used equally in both groups. The incidence of ultrafiltration failure was significantly higher in the acidic group. At the start of PD, neither residual renal function nor UFV differed between the groups. However, at the end of PD, residual renal function and UFV were both significantly higher in the neutral group than in the acidic group. At the start of PD, PET results were not significantly different; however, by the end of PD, the dialysate-to-plasma ratio of creatinine had become significantly higher in the acidic group. The groups showed no significant difference in the use of angiotensin converting-enzyme inhibitors or angiotensin II receptor blockers, statins, or vitamin D. however, no significant correlation was observed in the neutral group [ Figure 3(c,d) ].
Peritoneal histology
Grade of AGE accumulation was reduced in neutral solution group
The grade of AGE accumulation in the interstitium and vascular wall was significantly higher in the acidic group than in the neutral and pre-PD groups. The total grade of AGE accumulation was also significantly higher in the acidic group than in the neutral and pre-PD groups ( Figure 4 ).
Peritoneal vessel density was increased in neutral solution group
The capillary density detected by staining for CD31 was significantly higher in the neutral group (90.4 ±3.3/mm2) than in the acidic (30.6 ± 3.5/mm2) and pre-PD groups [51.3 ± 3.3/mm2, Figure 5(a) ]. However, the podoplanin-positive lymphatic capillary density showed no significant difference between groups (neutral: 12.3 ± 0.9/mm2; acidic: 11.1 ± 1.1/mm2; pre-PD: 10.6 ± 0.8/mm2). The density of CD31-positive capillaries was significantly and Kawanishi et al. Numata et al. (27) reported that increased peritoneal transport is associated with relative vascular area, but not with relative vessel number.
In the present study, the cause of increased vascular density in the neutral group compared with the acidic group remains uncertain. Krediet et al. (13) proposed that high concentrations of glucose and lactate may be the principal factors promoting angiogenesis.
Considering that hypothesis, we speculate that the new biocompatible solutions may eventually reduce the toxic effects of GDPs and may promote angiogenic responses with high glucose and lactate levels, which are still present in the new solutions.
Lymphangiogenesis has been reported to occur in various diseases of kidney (28) and peritoneum in an experimental PD model (29) , and lymphatic vessels are speculated to be involved in peritoneal transport and PD-related peritoneal disorders. However, the vessels that increased in density in the neutral group were not lymphatic vessels but blood vessels, and the role of lymphatic vessels in the pathogenesis of PD-related peritoneal deterioration was not demonstrated in the present study.
Although increased vascular density was observed in the neutral group, it was not correlated with peritoneal hyperpermeability to small molecules (creatinine and glucose) as determined by a PET. In contrast, the grade of AGE accumulation was significantly correlated with peritoneal hyperpermeability, indicating that GDPs may play a more important role in peritoneal hyperpermeability through AGE accumulation. Factors other than vascular density-such as impaired endothelial cell function or vascular integrity induced by GDPs-might have an important role in regulating peritoneal permeability. The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, please see:
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